The Future of Tissue Engineering & Cell Therapy Markets to 2028

The global tissue engineering and cell therapy market stood at nearly $12.68 billion in 2017 and is forecast to see an annual average growth rate of 26% to reach a value of approximately $171.9 billion by 2028.

£4,500.00

Add to basket Enquire
Product detail
Product type: Market report
Date of publication: 09 Jul 2018
Product format: Digital Copy, Hard Copy
Number of tables: 151
  • Tissue engineering, once considered a sub-field of biomaterials, has grown in breadth and depth and is now a fully-fledged industry.
     
  • This report covers engineered or regenerated biological tissues and the products used to create them that are then applied to the treatment of disease and trauma.
     
  • The report also covers autologous cell therapy (if the cells have been engineered or genetically manipulated) and allogeneic cell therapy, including the use of stem cells, again for the treatment of disease and trauma. Finally, this report includes cellular immunotherapies and gene therapies.
  • The Future of Tissue Engineering and Cell Therapy to 2028 provides detailed analysis of these applications which includes cardiology, neurology, gastroenterology, autoimmune diseases, urology, skin, periodontics, organ repair and replacement, gynaecology and several types of cancer.

Description

Our exclusive content:

  • In-depth analysis of current technologies and innovations within the tissue engineering and cell therapy markets to 2028
  • Detailed examination of developments in tissue engineering and cell therapy by clinical area
  • A global overview of regulatory requirements and the reimbursement landscape

What methodology is used?

The Future of Tissue Engineering and Cell Therapy to 2028 is based on extensive primary and secondary research frommultiple information sources. Primary research consisted of surveys and interviews with marketing/sales executives and other
senior management at tissue engineering and cell therapy companies, clinicians in this field and other stakeholders (regulatory, reimbursement, investment) in this industry. Secondary research was compiled using industry data such as company marketing literature, company annual reports, regulatory filings, peer-reviewed clinical publications, investment reports and others. Statistical data from government and non-government sources was also used to compile this report as well as published coverage policies by major third-party players.

What will you discover?

  • Gain a complete overview of the tissue engineering and cell therapy industry
  • Detailed analysis of applications including cardiology neurology, gastroenterology, autoimmune disease, urology, skin, periodontics, organ repair and replacement, gynaecology and several types of cancer
  • Comprehensive market analyses by region and application

Who should by this report?

  • Tissue engineering and cell therapy product manufacturers
  • Medical and surgical instrument manufacturers
  • Clinical suppliers
  • Raw material suppliers
  • Research/testing laboratories
  • Consultants and analysts
  • Venture capitalists and
  • other investors

Table of Contents

Executive summary

Introduction and methodology

  • Objectives
  • Scope of this report
  • Methodology
  • Definition

Background

  • Overview
  • Tissue engineering supportive technologies
  • Biomaterials scaffolds
  • Nanotechnology
  • 3D bioprinting
  • Cryopreservation and storage technologies
  • Cell therapy research and technology
  • Overview of cell therapy
  • Overview of stem cells
  • Towards the use of cell therapy
  • Cell therapy production
  • Recent developments in cell therapy production
  • The International Cell Therapy Banking Initiative project

Clinical disorders and treatment needs

  • Overview of cancer treatment needs

    • Melanoma
    • Pancreatic cancer
    • Haematopoiesis
  • Cardiovascular and vascula
    • Congestive heart failure
    • Heart attack
    • Dysfunctional heart valves
    • Peripheral vascular disorders
      • Abdominal aortic aneurysm
      • Brain aneurysm
        • Ischemic stroke
  • Autoimmune diseases
    • Graft versus host disease (GvHD)
  • Orthopaedics
    • Non-union fractures
    • Cartilage and connective tissue damage and repair
    • Ligament damage
    • Vertebral disc damage
    • Osteoarthritis
  • Urological
    • Corporal bodies
    • Urethra
    • Bladder
  • Skin, integumentary system
    • Wound healing
    • Hair
  • Dental
    • Missing teeth
    • Gum disease
  • Organ replacement and repair
    • Pancreas
      • Diabetes mellitus
    • Lung
    • Liver
    • Kidney
  • Opthalmology
    • Cornea
    • Retina
  • General, gastrointestinal, gynaecological and other
    • Crohn’s disease
    • Nerve and neurological conditions
    • Ear repair or replacement
    • Nose repair or replacement
    • Esophagus
    • Trachea
    • Stomach
    • Small Intestine
    • Large Intestine
    • Bladder
    • Uterus
    • Cervix
    • Penis
    • Other

Tissue engineering and cell therapy developments by clinical area

  • Developments with applications in most or all clinical areas
    • Biodegradable scaffold design for design for delivery of cells, factors
    • 4D tissue engineering
  • Cancer
  • Cardiovascular and vascular
  • Orthopaedics
  • Periodontics
  • Organ replacement and repair
  • Ophthalmology
  • General, gastrointestinal, gynaecological and other
  • Overview key tissue engineering and cell therapy clinical trials

Global regulatory and reinbursement landscape

  • Regulatory
  • Reimbursement
  • Intellectual property and key patents
    • Stem cell patents
      • The patentability of stem cell lines
      • Individual country policies
    • Tissue engineering and cell therapy patents

Tissue engineering and cell therapy industry overview

  • Intensity of competition
  • Merger and acquisition activity
  • Market dynamics
  • Growth drivers and restraints
  • Investment levels
  • Opportunities in tissue engineering and cell therapy

Tissue engineering and cell therapy market by region

  • Global market for tissue engineering and cell therapy
  • US market for tissue engineering and cell therapy
  • European Union market for tissue engineering and cell therapy
  • Japan market for tissue engineering and cell therapy
  • Rest of World market for tissue engineering and cell therapy
  • Global market for cancer related tissue engineering and cell therapy
    • US
    • European Union
    • Japan
    • Rest of World
  • Global market for cancer tissue engineering and cell therapy
    • US
    • European Union
    • Japan
    • Rest of World
  • Global market for cardiovascular and vascular tissue engineering and cell therapy
    • US
    • European Union
    • Japan
    • Rest of World
  • Global markets for autoimmune tissue engineering and cell therapy
    • US
    • European Union
    • Japan
    • Rest of World
  • Global markets for orthopaedic tissue engineering and cell therapy
    • US
    • European Union
    • Japan
    • Rest of World
  • Global markets for urological tissue engineering and cell therapy
    • US
    • European Union
    • Japan
    • Rest of World
  • Global markets for skin/integumentary tissue engineering and cell therapy
    • US
    • European Union
    • Japan
    • Rest of World
  • Global markets for dental tissue engineering and cell therapy
    • US
    • European Union
    • Japan
    • Rest of World
  • Global markets for organ replacement and repair tissue engineering and cell therapy
    • US
    • European Union
    • Japan
    • Rest of World
  • Global markets for ophthalmology tissue engineering and cell therapy
    • US
    • European Union
    • Japan
    • Rest of World
  • Global markets for general, gastrointestinal, gynaecological and other tissue engineering and cell therapy
    • US
    • European Union
    • Japan
    • Rest of World

Company profiles

Tables and Figures

  • Summary markets, 2017–2028
  • Summary market shares, 2017
  • Incidence of
    • Congestive heart failure
    • Myocardial infarction
    • Dysfunctional heart valves
  • Incidence & prevalence of
    • Melanoma
    • Pancreatic cancer
    • Peripheral vascular disorders
    • Abdominal aortic aneurysm
    • Brain aneurysm
    • Ischemic stroke
    • Graft vs. host disease
    • Non-union fractures incidence
    • Cartilage and connective tissue damage
    • Vertebral disc damage
    • Difficult-to-heal wounds
    • Baldness
    • Periodontal diseases
    • Diabetes mellitus
    • Lung disease
    • Liver disease
    • Kidney disease
    • Corneal disease
    • Retinitis pigmentosa
    • Age-related macular degeneration
    • Crohn’s disease
    • Amyotrophic lateral sclerosis
    • Parkinson’s disease
    • Eplilepsy
    • Spinal cord injury
    • Multiple sclerosis
  • Product/technology innovations applicable to broad clinical areas
  • Product/technology innovations with
    • Cancer treatment applications
    • Cardiovascular and vascular treatment applications
    • Orthopaedic treatment applications
    • Urological treatment applications
    • Periodontal applications
    • Applications in organ replacement and repair
    • Applications in ophthalmology
  • Market for cardiovascular & vascular related tissue engineering and cell therapy, 2017–2028 ($ million)
  • US
  • EU
  • UK
  • France
  • Germany
  • Italy
  • Spain
  • Japan
  • Rest of world
  • Global market for autoimmune tissue engineering and cell therapy, 2017–2028 ($ million)
  • Market for autoimmune tissue engineering and cell therapy, 2017–2028($ million)
    • US
    • EU
    • UK
    • France
    • Germany
    • Italy
    • Spain
    • Japan
    • Rest of world
  • Global market for orthopaedic tissue engineering and cell therapy, 2017–2028 ($ million)
  • Market for orthopaedic tissue engineering and cell therapy, 2017–2028 ($ million)
    • US
    • EU
    • UK
    • France
    • Germany
    • Italy
    • Spain
    • Japan
    • Rest of world
  • Global market for neurological tissue engineering and cell therapy, 2017–2028 ($ million)
  • Market for neurological tissue engineering and cell therapy, 2017–2028 ($ million)
    • US
    • EU
    • UK
    • France
    • Germany
    • Italy
    • Spain
    • Japan
    • Rest of world
  • Market for urological tissue engineering and cell therapy, 2017–2028 ($ million)
  • Global market for skin/integumentary tissue engineering and cell therapy, 2017–2028 ($ million)
  • Market for skin/integumentary tissue engineering and cell therapy, 2017–2028 ($ million)
    • US
    • EU
    • UK
    • France
    • Germany
    • Italy
    • Spain
    • Japan
    • Rest of world
  • Global market for dental tissue engineering and cell therapy, 2017–2028 ($ million)
  • Market for dental tissue engineering and cell therapy, 2017–2028 ($ million)
    • US
    • EU
    • UK
    • France
    • Germany
    • Italy
    • Spain
    • Japan
    • Rest of world
  • Global market for organ replacement & repair tissue engineering and cell therapy, 2017–2028 ($ million)
  • Market for organ replacement & repair tissue engineering and cell therapy, 2017–2028 ($ million)
    • US
    • EU
    • UK
    • France
    • Germany
    • Italy
    • Spain
    • Japan
    • Rest of world
  • Global market for ophthalmological tissue engineering and cell therapy, 2017–2028 ($ million)
  • Market for ophthalmological tissue engineering and cell therapy, 2017–2028 ($ million)
    • US
    • EU
    • UK
    • France
    • Germany
    • Italy
    • Spain
    • Japan
    • Rest of world
  • Global market for general, GI, GYN & other tissue engineering and cell therapy, 2017–2028 ($ million)
  • Market for general, GI, GYN & other tissue engineering and cell therapy, 2017–2028 ($ million)
    • US
    • EU
    • UK
    • France
    • Germany
    • Italy
    • Spain
    • Japan
    • Rest of world